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Abstract
BACKGROUND: A low-sodium diet is a core component of heart failure self-care but patients have difficulty
following the diet.
AIM: The aim of this study was to identify predictors of higher than recommended sodium excretion among
patients with heart failure.
METHODS: The World Health Organization Five Dimensions of Adherence model was used to guide
analysis of existing data collected from a prospective, longitudinal study of 280 community-dwelling adults
with previously or currently symptomatic heart failure. Sodium excretion was measured objectively using
24-hour urine sodium measured at three time points over six months. A mixed effect logistic model identified
predictors of higher than recommended sodium excretion.
RESULTS: The adjusted odds of higher sodium excretion were 2.90, (95% confidence interval (CI):
1.15-4.25, pp=0.007) for patients with diabetes; and 2.22 (95% CI: 1.09-4.53, p=0.028) for patients who were
cognitively intact.
CONCLUSION: Three factors were associated with excess sodium excretion and two factors, obesity and
diabetes, are modifiable by changing dietary food patterns.
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Abstract
Background—A low-sodium diet is a core component of heart failure self-care but patients have 
difficulty following the diet.
Aim—The aim of this study was to identify predictors of higher than recommended sodium 
excretion among patients with heart failure.
Methods—The World Health Organization Five Dimensions of Adherence model was used to 
guide analysis of existing data collected from a prospective, longitudinal study of 280 community-
dwelling adults with previously or currently symptomatic heart failure. Sodium excretion was 
measured objectively using 24-hour urine sodium measured at three time points over six months. 
A mixed effect logistic model identified predictors of higher than recommended sodium excretion.
Results—The adjusted odds of higher sodium excretion were 2.90, (95% confidence interval 
(CI): 1.15–4.25, p<0.001) for patients who were obese; 2.80 (95% CI: 1.33–5.89, p=0.007) for 
patients with diabetes; and 2.22 (95% CI: 1.09–4.53, p=0.028) for patients who were cognitively 
intact.
Conclusion—Three factors were associated with excess sodium excretion and two factors, 
obesity and diabetes, are modifiable by changing dietary food patterns.
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Introduction
Heart failure is a major public health concern because it is associated with high morbidity, 
mortality and cost. Self-care is recognized as a means of improving these outcomes.1 
Consuming a low-sodium diet is one of the most frequently recommended self-care 
behaviors; 2–5 however, it is estimated that only 22–55% of patients with heart failure are 
adherent to a low-sodium diet.6–8 The rationale for not consuming excessive sodium is that 
it can lead to fluid retention, higher ventricular filling pressures and symptoms of 
congestion9—all of which put patients with heart failure at risk for acute decompensation 
and hospitalization.10,11
The general recommendation for all adults in the United States is to consume less than 2300 
mg of sodium a day; however, the average American consumes approximately 3400 mg of 
sodium per day.12 Sodium is one of the primary cations in extracellular fluid. By influencing 
the shifting of water between body compartments, it plays an important role in maintaining 
body fluid tonicity, blood volume and pressure. The Heart Failure Society of America 
(HFSA) guidelines recommend that patients with symptoms of heart failure restrict daily 
sodium intake to 2000–3000 mg/ day.6 The most recent 2013 American Heart Association 
(AHA) guideline for the management of heart failure recommends sodium restriction 
(<3000 mg/day) for patients with stage C and D heart failure.13
Patients with heart failure face a number of barriers to effectively quantifying sodium intake 
and maintaining a low-sodium diet. A major barrier is that many patients do not find low-
sodium foods palatable and consequently never adjust to the taste of low-sodium foods and 
change their eating habits.14 A lack of knowledge about how to identify high-sodium foods, 
even when labeled, is also a barrier for patients.14–17 Few restaurants offer low-sodium 
options, which decreases dining out opportunities for socialization with friends.14–16 
Overall, there are multiple barriers that can impede patients with heart failure from 
consistently following a low-sodium diet.
The aim of this study was to identify socio-demographic and clinical characteristics that 
predict higher than HFSA-recommended sodium intake, estimated by urinary sodium 
excretion, using longitudinal data of patients with heart failure. For the purposes of this 
study, we assumed that sodium excretion was a reflection of sodium consumption. The 
World Health Organization (WHO) Five Dimensions of Adherence model was used to 
identify factors potentially associated with poor dietary adherence.18 This holistic model 
acknowledges the multi-dimensionality of adherence including social and economic 
conditions, the health care system, as well as condition-, therapy- and patient-related 
factors.18 Previously, this model has been used to guide the assessment of medication 
adherence in patients with heart failure.19
Methods
Study population
This study was a secondary analysis of data collected in an observational prospective cohort 
study of 280 community-dwelling adults with previously or currently symptomatic heart 
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failure who were followed over a six-month time period. This study was in compliance with 
the Declaration of Helsinki.20 Institutional Review Board approval was obtained from all 
three sites and all participants gave written informed consent. The parent study was 
conducted to investigate the relationship between excessive daytime sleepiness and heart 
failure self-care. The detailed methodology of this study has been reported elsewhere.21 In 
brief, this was a prospective cohort study with patients assigned to one of four cohorts based 
on excessive daytime sleepiness and cognitive decline. Multiple heart failure self-care 
behaviors were measured including eating a low-sodium diet, which was assessed with 24-
hour urine sodium specimens at three time-points (enrollment, three- and six-months). 
Patients with heart failure were prospectively enrolled from three outpatient settings, two in 
Pennsylvania and one in Delaware, between 2007 and 2010. The basic eligibility criteria for 
participation included: (a) chronic heart failure with prior or current symptoms, (b) ability to 
read and speak English, and (c) sufficiently able to complete questionnaires and study 
procedures (i.e. adequate cognition, English fluency, ability to read). Patients were ineligible 
to participate in the study if they had dementia, as measured by the Telephone Interview for 
Cognitive Status22 along with other criteria specified in the parent study.21 Most participants 
in this study were followed in specialty heart failure clinics and were on standard medical 
therapy. The usual care provided by heart failure specialty clinics was not augmented in this 
observational study.
Variables and measures
Clinical information (e.g. etiology and type of heart failure, left ventricular ejection fraction 
(LVEF), and comorbid illnesses) was abstracted from the medical record by a registered 
nurse at each of the three enrollment sites. These nurses were familiar with the unique 
electronic medical record systems in their own setting. Each nurse received extensive 
training to assure consistency of data collection. The principal investigator assured the 
fidelity of the data collection protocol at each site and was available for questions 
throughout the study period.
Comorbidities (including diabetes) were scored with the Charlson Comorbidity Index, a 
commonly used measure,23 directly from the medical record. In this sample, all patients had 
a score of at least one because they all had heart failure. Validity was demonstrated by the 
instrument authors when comorbidity scores (categorized as low, medium, and high) 
predicted risk of 10-year mortality, complications, health care resource use, length-of-
hospital-stay, discharge disposition and cost.23–26
New York Heart Association (NYHA) functional class was scored Class I–IV by a single 
board certified cardiologist using data obtained from a standardized interview.27 Body mass 
index (BMI) was calculated based on the patient’s weight at the baseline visit and self-
reported height. Detailed information on participants’ medications, with doses, was collected 
at each data collection period. Sociodemographic characteristics were self-reported.
Cognition was measured with a battery of neuropsychological tests administered in person 
by trained research assistants. The number of tests on which participants scored below their 
age-based norm was used as an indicator of cognitive status. Any participant who scored 
more than 1.5 standard deviations (SDs) beyond the range of normal on at least two of the 
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paper-and-pencil tests was considered to have mild cognitive decline. For analysis, the 
cognition variable was dichotomized to indicate those with or without cognitive impairment. 
The details of the neurocognitive battery and methodology for categorizing cognitive status 
are reported in detail in the parent study.21
In this study, dietary sodium intake was approximated using urine sodium excretion. Sodium 
is under tight homeostatic control and is only lost from the body as sweat (20–80 mmol/
day), stool (5–10 mmol/day) or urine (1–500 mmol/day).28 Patients with heart failure do not 
typically engage in strenuous physical activity; therefore do not lose sodium from heavy 
perspiration. Variations in sodium excretion are primarily due to variations in recent sodium 
intake.29 In this study, we made the assumption that the 24-hour urinary sodium excretion 
samples reflected dietary sodium intake across the study period, consistent with previous 
studies.10,30,31 The 24-hour urine collection method has been validated by urine recovery of 
oral doses of para-amino benzoic acid 32–34 and the collection procedures followed in the 
parent study were consistent with recommendations for collection by the Institute of 
Medicine.35
Based on criteria set forth by the 2010 HFSA practice guidelines and published papers, urine 
sodium in mmoles was converted to mg (mg= mmole×22.99).5,10 The urine sodium binary 
outcome in this study was created using 3000 mg/day 24-hour urine sodium cut-off point for 
patients in NYHA Class I/II and a 2000 mg/day 24-hour cut-off point for patients in NYHA 
Class III/IV. Expected dietary sodium categories were compared between participants whose 
dietary sodium excretion was within recommended levels versus those in higher than 
recommended levels.
Procedures
Data were collected at baseline, three-months, and six-months by research assistants during 
home visits. Training for urine specimen collection was provided for the patient and family 
member, if available, at the baseline data collection interval. Prior to each subsequent urine 
collection, patients were telephoned to remind them and reinforce training for the procedure. 
Patients were given urine containers, collection devices, verbal and written instructions 
(with pictures) specifying when they should start and finish collecting the urine specimen. 
Participants were instructed to start the collection at 08:00, discard that specimen, and 
collect the final specimen at 08:00 on the following day. Prior to the patient collecting each 
urine specimen, the research assistant inquired about changes in the medication regimen. If 
the participant had experienced a recent medication change the collection was delayed for 
three days starting from the date the medication was changed. Participants recorded when 
their urine sodium collection started and finished. A courier picked up the specimens from 
the participant’s homes after the 24-hour sample was completed.
The central laboratory at the Hospital of the University of Pennsylvania analyzed the urine 
samples to determine the amount of sodium in each specimen using the ion-selective 
electrode method (Beckman LX 20 Chemistry Analyzer, Beckman Coulter, Inc., Fullerton, 
California, USA).
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Statistical analysis
Descriptive statistics were used to calculate frequencies with percentages and means with 
standard deviation (SD) for the total sample, urine sodium in g per day, and sodium 
consumption. Chi-square and Kruskal-Wallis tests were used to compare baseline 
characteristics of binary, categorical and ordinal variables between groups. For the purposes 
of between group comparisons, the doses for patients on loop diuretics (n=83) were 
converted to furosemide equivalents using the following formula: furosemide 80 
mg=torsemide 40 mg=bumetanide 2 mg.36 The other participants on diuretics (n=8) were 
prescribed hydrochlorothiazide and compared separately. This method has been used in 
other studies.10
Over the three points of data collection, data on the urine sodium excretion were missing 
overall in 23% of the participants (193/840 samples), 19% at baseline, 29% at three-months 
and 23% at six-months. Multiple imputations were performed for urinary sodium excretion 
and BMI data to account for missing time-varying covariates.37–39 Multiple imputation is a 
principled, likelihood-based method using statistical modeling to impute data using the 
method of chained equations.40 In short, this method creates 10 copies of the data, as 
recommended by Rubin.39 The multiple imputations were based on baseline age, gender, 
etiology of heart failure, cognitive status and LVEF and complete data for time-varying 
covariates, including NYHA class, BMI and urine sodium excretion. Each dataset was then 
analyzed separately.41 Estimates of the parameters of interest were averaged across all the 
datasets to give a single, final estimate.41,42 After imputation, data were checked to confirm 
reasonable values. Standard errors and 95% confidence intervals (CIs) were estimated by 
calculating within and between components of variance using the method of Rubin.39
To determine predictors of higher than recommended sodium intake, a mixed effect logistic 
model with a random intercept was tested for each patient. Adjusted odds ratios (ORs), 95% 
CIs and p-values are presented for statistically significant predictors of higher than 
recommended sodium intake fit on the imputed data.43 The selection of model covariates 
was based on four of the five dimensions of adherence from the WHO conceptual model: 
condition, therapy, patient-related factors and social and economic conditions as well as 
statistical association with the outcome variable, urine sodium excretion. The final 12 
covariates included in the multivariable regression models are presented in Table 1.44
Two sensitivity analyses were conducted. First, mixed effect logistic estimates were 
compared between the complete case and imputed data models. Estimates based on imputed 
data were more conservative in terms of effect sizes and had narrower CIs. This was 
expected because CIs and model variance depend on the amount of missing data, sample 
size and number of imputed datasets.40,45 Second, estimates from the mixed effects logistic 
models were confirmed with generalized estimating equations models with robust standard 
errors. Data are not shown for these two sensitivity analyses because there were no 
significant differences between the models. All data analyses were performed using Stata v. 
11.2.46
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Results
This sample of patients with heart failure had a mean age of 62 years (SD=12), was 
predominantly male (64%), functionally compromised (77% in NYHA class III or IV) with 
a mean LVEF of 35 (SD: 17). Over one-third of the sample had diabetes. Among 
participants with diabetes, 60% were also obese. Over two-thirds of the sample had 
hypertension, and about 20% had chronic obstructive pulmonary disease. Sample 
demographic and clinical characteristics are shown in Table 2. The urine sodium levels were 
relatively normally distributed so mean and standard errors are presented. The majority of 
the sample was prescribed furosemide or an equivalent loop diuretic.
The median and interquartile range values for urine sodium excretion on the complete cases 
at all three time points were 2770 mg (1750–3950 mg) at baseline, 2630 mg (1690–4000 
mg) at three-months and 2780 mg (1900–3790 mg) at six-months. There was no trend in 
sodium excretion across time that would suggest that participants modified their diets in 
anticipation of these measurements. We found no difference in the pattern of observed 
values for participants with missing data and those with complete observations.
In the final model identifying patient characteristics associated with higher than 
recommended sodium intake (Table 3), patients with heart failure who were obese 
(BMI>30) had nearly three times higher adjusted odds of consuming more than 
recommended sodium intake compared to patients with a normal body weight (BMI<25). 
The adjusted odds of sodium intake above recommended level were over two times higher 
in patients who were cognitively intact compared to patients with some cognitive 
impairment. Patients with heart failure and diabetes had almost three times the adjusted odds 
of consuming more than the recommended sodium intake.
Discussion
The purpose of the study was to identify characteristics of patients with heart failure who 
had higher than recommended 24-hour urine sodium excretion. In this study, we used 24-
hour sodium excretion as an estimate of dietary sodium intake, or adherence to sodium 
guidelines. Considering possible predictors drawn from the WHO adherence model, the 
three most important predictors of higher sodium excretion were patient- and condition-
related factors. Patients with heart failure who were obese or had diabetes and those who 
were cognitively intact were more likely to excrete higher amounts of sodium.
The association between higher sodium and obesity is most likely explained by both direct 
and indirect effects.31,47 One explanation for the relationship between obesity and higher 
sodium consumption is that high-calorie foods often contain high sodium.48 Increased 
dietary sodium intake is directly correlated with increased calorie consumption.30,49 
According to the Salted Food Addictive Hypothesis, salted foods act in the brain like an 
opiate agonist, producing a hedonistic reward, which becomes associated with foods being 
judged as “delicious” or “flavorful.”47 Withdrawal of salty foods acts like an opiate receptor 
withdrawal and causes perceived “cravings” for salted foods.47 Over time, daily 
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consumption of salted foods can produce an addiction, which escalates and can stimulate 
overeating.50
The association between high sodium intake and obesity has also been found in rat animal 
models51 and has a physiological explanation: chronic salt overload induces adipocyte 
hypertrophy, which enhances insulin sensitivity for glucose uptake and insulin-induced 
glucose metabolism.51 Song and colleagues report a direct effect between sodium intake and 
risk of being overweight in humans, after adjusting for energy, water, and soda 
consumption;31 however, their study sample did not include patients with heart failure, 
hypertension or diabetes. The relationship between obesity and sodium consumption is 
consistent with results of our previous study in which we found that patients with heart 
failure who were overweight had a four-fold increased odds of consuming more than 3000 
mg of sodium per day.52
Other lifestyle factors may help explain the relationship between obesity and sodium 
consumption. Processed and packaged foods are naturally high in sodium because sodium is 
a natural preservative that increases the shelf life of foods. Patients with heart failure often 
feel fatigued and may have less energy to dedicate to the purchase and preparation of low-
sodium food. Originally, we thought that purchasing fresh produce and meat may be 
prohibitively expensive for patients on fixed or limited incomes; however, income was not a 
statistically significant predictor of higher sodium excretion. Another important question is 
whether the guidelines should recommend varying amounts of sodium intake for people 
with heart failure with different body weight and other clinical characteristics. According to 
Gupta and colleagues, reporting in 2012, there is still uncertainty as to whether dietary 
sodium intake recommendations should be individualized.9
Diabetes was a strong predictor of higher than recommended sodium intake. This may be 
explained by the fact that any form of kidney disease in which tubular reabsorption of 
filtered sodium does not match the filtered load plus dietary intake can cause renal sodium 
wasting (i.e. hyperfiltration occurring in earlier stages of diabetic nephropathy). The finding 
that diabetes is a predictor of higher sodium intake is consistent with a previous analysis in 
which patients with diabetes were four times as likely to consume more than 4 g of sodium 
per day over time.52 This finding may be explained by the association between diabetes and 
obesity, in which case diabetes is acting as a marker of obesity.
In the literature, associations between mild cognitive impairment and heart failure self-care 
behaviors are mixed.1,53,54 Mild cognitive impairment has been associated with worse self-
care management55,56 probably because of an inability to perform the complex decision-
making required to manage signs and symptoms. An association between cognitive 
impairment and poorer self-care maintenance such as eating a low sodium diet has not been 
reported. In a study by Cameron and colleagues, the majority of patients (73%) had 
unrecognized or subclinical cognitive impairment and were as likely to engage in health-
promoting behaviors, such as daily weighing, as those without cognitive impairment.56 
Dickson and colleagues reported that poorer cognition was associated with better self-care 
behaviors among patients with heart failure in a mixed-methods study.57 It is important to 
note that these prior studies focused on the subjective assessment of multiple self-care 
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behaviors and not exclusively on dietary sodium. Further, there were considerable 
differences across studies in the methods of measuring cognition that may, in part, explain 
differences in study findings.57
While it may be assumed that patients with mild cognitive impairment will not be able to 
follow a low-sodium diet that was not the case in this study. Patients who were cognitively 
intact had more than double the odds of consuming higher than recommended sodium levels 
compared to patients with cognitive impairment. This seemingly counter-intuitive finding 
may be explained by the fact that patients with cognitive impairment often have caregivers 
who make and provide their meals. Patients who are cognitively intact may be more self-
reliant in making dietary decisions. This finding could also be explained by the rigidity that 
is associated with cognitive impairment.58,59 Rigidity refers to the tendency to form and 
repeat particular behaviors; eating the same foods is one form of rigidity. We cannot confirm 
either of these hypotheses because we did not collect data on caregivers or rigidity 
associated with specific dietary choices in this study.
Many patients with heart failure struggle to consume levels of sodium that are considered 
moderate. In a study of adults with heart failure from the Southern US, only 33% of 
individuals consumed 2000 mg/day or less with the wide range of 522–9251 mg/day.60 
Likewise, based on 24-hour urinary sodium excretion levels, another study reported that 
34% of the sample was compliant with recommendations to consume less than 3000 mg/day 
and only 15% consumed less than 2000 mg/day.10
Recently, sodium restriction for patients with heart failure has been questioned due to wide 
variation in the study protocols, study samples, fluid intake, measurement of sodium intake 
and compliance.13 Some studies have even questioned any sodium restriction;61,62 however, 
this was largely due to a very rigid definition of sodium intake (80 mmol/day).61 Paterna and 
colleagues recommend a normal sodium diet, defined as 120 mmol/ day (about 2800 mg/
day) 61,62 which is consistent with the recommendation of <3 g a day for patients with Class 
C and D heart failure.13 Overall, the message across these studies and a recent review by 
Gupta and colleagues is consistent— high sodium intake is not optimal for patients with 
heart failure because excessive sodium intake is associated with fluid retention; however, the 
lower-dose range of sodium intake needs to be better defined, and possibly individualized to 
patients in future studies.9
Strengths and limitations
One of the strengths of this study was the repeated measures of sodium excretion on the 
same individuals over a six-month period. Multivariate statistical methods were used for 
these repeated measures to account for the correlation of measures within an individual, 
which reduced measurement error and individual variability. The use of longitudinal data in 
this study also provided a clearer picture of how well patients followed a low-sodium diet 
over an extended period of time, instead of one point in time. Another strength of the study 
is that we used robust and transparent imputation methods to address potential bias from 
incomplete data.37,39
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The study also had several limitations including the fact that this was a secondary analysis of 
a dataset that did not include measures of sodium intake. Data from carefully controlled 
studies show that at least seven days of direct measurement of sodium intake and excretion 
in the urine are needed to achieve correlations of 0.8,63 which implies that food records and 
urine excretion provide complementary information about sodium intake. The relationship 
between sodium intake and excretion is analogous to fasting blood glucose and hemoglobin 
A1c in diabetic patients. These two measures provide similar, but different, information 
about dietary adherence in patients with diabetes. In this study, our intention was not to 
precisely estimate sodium intake over the previous 24 hours, but to estimate general 
adherence to dietary recommendations. For our purposes, 24-hour sodium excretion was the 
best available marker of dietary sodium consumption.
Another limitation of this study was that patients in this sample were on loop diuretics, 
which enhance urinary excretion of sodium by inhibiting tubular reabsorption at the thick 
ascending limb of the Loop of Henle, in the nephron. Arcand and colleagues, in 2010, found 
no statistically significant relationship between 24-hour urine sodium excretion and sodium 
intake from food records in patients with heart failure on a loop diuretic; however, they 
reported significant correlations for non-heart failure cardiac patients and for patients with 
heart failure who were not prescribed a loop diuretic.64 While informative, limitations of the 
Arcand study were that it used a cross-sectional, correlational design in a young, relatively 
small sample of patients with heart failure in which other relevant variables that may explain 
the differences in sodium excretion were not controlled. Though there may be some 
imprecision from using urinary sodium excretion as a measure of dietary sodium intake for 
patients on loop diuretics, it is still considered the best measure for patients with heart 
failure.10,30,65 In addition, we statistically controlled for diuretic use.
There are inherent limitations to a secondary data analysis, including the fact that this study 
was limited by the demographics and size of the original sample. For example this sample 
was younger than most other community-dwelling samples of patients with heart failure so 
the results may not be generalizable to older adults with heart failure. There may be 
additional predictors of higher sodium intake that were not measured in the parent study, 
such as fluid intake, and thus could not be controlled for. In addition, while it was a strength 
that we used four of the five dimensions of adherence in the WHO model, the dimensions 
were not measured comprehensively. For instance, due to the sample size, we were 
restricted to including only variables that were both conceptually consistent with the WHO 
dimensions as well as statistically associated with sodium excretion in the final model. Some 
dimensions may not have been fully captured by the variables selected.
Conclusion
Patients with heart failure who are cognitively intact, those who have diabetes or are obese 
are at risk for consuming more sodium than recommended. The 2013 report of the AHA 
guidelines for the management of heart failure recommends reasonable sodium restriction 
for patients with symptomatic heart failure to reduce congestive symptoms13 and the HFSA 
guidelines recommend that all patients with heart failure be provided with dietary 
instruction.5 Sodium dietary instructions should be contextualized within a longer 
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conversation with patients about their general sodium intake. Further research may support 
identifying higher risk patients and intervening to help them decrease their sodium intake. 
Ultimately interventions around dietary sodium intake may help decrease the risk of 
decompensation and re-hospitalization for patients with heart failure.11,66
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Implications for practice
• Patients who have diabetes, are obese or are cognitively intact might be at risk 
for consuming more sodium than recommended.
• Further research should identify patients and intervene to help them reduce high 
sodium consumption with tailored dietary interventions.
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Table 1
World Health Organization five dimensions of adherence model.
Dimension of adherence Variables used in this study
Social/economic factors Race, income, highest level of education
Therapy-related factors Diuretic (loop or thiazide)
Patient-related factors Gender, age, body mass index, cognitive status
Condition-related factors Heart failure type (diastolic or systolic), diabetes, hypertension, etiology (ischemic or non-ischemic)
Health-system factors Not available in this study
Eur J Cardiovasc Nurs. Author manuscript; available in PMC 2015 April 06.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Creber et al. Page 16
Ta
bl
e 
2
D
em
og
ra
ph
ic
, s
oc
ia
l a
nd
 c
lin
ic
al
 c
ha
ra
ct
er
ist
ic
s o
f p
at
ie
nt
s, 
m
ea
n 
24
-h
ou
r u
rin
e 
so
di
um
 (N
a+
) s
am
ple
s a
nd
 w
he
the
r t
he
y w
ere
 w
ith
in 
or 
hig
he
r t
ha
n 
re
co
m
m
en
de
d 
H
FS
A
 g
ui
de
lin
es
.
V
ar
ia
bl
es
To
ta
l %
M
ea
n 
U
rN
a 
g/
da
y 
(S
E)
N
a+
 ex
cr
et
io
n 
le
ve
ls 
W
ith
in
 o
r H
ig
he
r
p-
v
a
lu
e
A
ge
 
<
65
 y
ea
rs
16
5
41
3.
08
 (0
.03
)
48
63
0.
02
2
 
≥6
5 
ye
ar
s
11
5
59
2.
61
 (0
.03
)
52
37
G
en
de
r
M
al
e
18
0
64
3.
23
 (0
.24
)
61
66
0.
42
5
Fe
m
al
e
10
0
36
2.
81
 (0
.03
)
39
34
R
ac
e
B
la
ck
/o
th
er
10
5
38
2.
95
 (0
.02
)
33
37
0.
59
7
W
hi
te
17
5
62
3.
30
 (0
.04
)
67
63
In
co
m
e
M
or
e 
th
an
 n
ee
de
d
98
35
2.
75
 (0
.03
)
38
33
0.
26
9
En
ou
gh
 to
 m
ee
t n
ee
ds
13
7
49
3.
21
 (0
.03
)
51
48
Le
ss
 th
an
 n
ee
de
d
45
16
3.
35
 (0
.05
)
11
19
N
Y
H
A
 fu
nc
tio
na
l c
la
ss
 
Cl
as
s I
/II
66
23
3.
03
 (0
.04
)
33
17
0.
00
9
 
Cl
as
s I
II
16
4
59
3.
02
 (0
.03
)
49
68
 
Cl
as
s I
V
50
18
3.
28
 (0
.06
)
18
15
D
iu
re
tic
 u
se
a
Fu
ro
se
m
id
e 
eq
u.
 (m
g/d
ay
) n
=
18
3
18
3
3.
07
 (0
.15
)
72
69
0.
70
3
≤4
0 
m
g/
da
y
91
50
2.
97
 (0
.14
)
>
40
 a
nd
 ≤
12
0 
m
g/
da
y
63
34
3.
33
 (0
.27
)
>
12
0 
m
g/
da
y
29
16
3.
01
 (0
.27
)
H
yd
ro
ch
lo
ro
th
ia
zi
de
 (m
g/d
ay
)
8
3
3.
30
 (0
.53
)
1
3
0.
40
0
H
ea
rt 
fa
ilu
re
 e
tio
lo
gy
 (n
=
27
9)b
Is
ch
em
ic
10
2
36
3.
11
 (0
.03
)
35
38
0.
62
5
N
on
-is
ch
em
ic
17
7
64
3.
05
 (0
.03
)
66
61
B
M
I (
n
=
27
9)b
Eur J Cardiovasc Nurs. Author manuscript; available in PMC 2015 April 06.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Creber et al. Page 17
V
ar
ia
bl
es
To
ta
l %
M
ea
n 
U
rN
a 
g/
da
y 
(S
E)
N
a+
 ex
cr
et
io
n 
le
ve
ls 
W
ith
in
 o
r H
ig
he
r
p-
v
a
lu
e
N
or
m
al
 (1
8–
24
)
74
26
2.
39
 (0
.03
)
38
18
0.
00
1
O
ve
rw
ei
gh
t (
25
–2
9)
73
26
2.
86
 (0
.05
)
27
27
O
be
se
 (3
0+
)
13
3
48
3.
53
 (0
.02
)
35
55
H
ig
he
st 
le
ve
l o
f e
du
ca
tio
n
Le
ss
 th
an
 h
ig
h 
sc
ho
ol
27
10
2.
65
 (0
.07
)
11
7
0.
27
1
H
ig
h 
sc
ho
ol
 g
ra
du
at
e
10
2
36
3.
05
 (0
.03
)
39
35
M
or
e 
th
an
 h
ig
h 
sc
ho
ol
15
1
54
3.
12
 (0
.03
)
50
58
Ty
pe
 o
f h
ea
rt 
fa
ilu
re
Sy
sto
lic
19
4
69
3.
00
 (0
.02
)
76
69
0.
47
5
D
ia
sto
lic
 o
r m
ix
ed
86
31
3.
19
 (0
.05
)
24
31
Ch
ar
lso
n 
co
-m
or
bi
di
ty
Lo
w
14
9
53
2.
96
 (0
.04
)
56
50
0.
26
8
M
od
er
at
e
10
1
36
3.
13
 (0
.06
)
37
35
H
ig
h
30
11
3.
26
 (0
.09
)
7
15
D
ia
be
te
s
Y
es
10
7
38
3.
57
 (0
.05
)
23
47
0.
00
1
N
o
17
3
62
2.
72
 (0
.04
)
77
53
H
yp
er
te
ns
io
n
Y
es
18
1
65
3.
06
 (0
.02
)
65
63
0.
72
9
N
o
99
35
3.
07
 (0
.03
)
35
37
CO
PD
Y
es
22
2
79
2.
53
 (0
.06
)
73
81
0.
12
9
N
o
58
21
3.
20
 (0
.03
)
27
19
Co
gn
iti
on
0.
00
4
Co
gn
iti
ve
ly
 im
pa
ire
d
10
7
39
2.
90
 (0
.02
)
47
28
N
ot
 c
og
ni
tiv
el
y 
im
pa
ire
d
16
5
61
3.
14
 (0
.03
)
53
72
a
D
iu
re
tic
 u
se
: T
hi
s o
nl
y 
in
cl
ud
es
 in
fo
rm
at
io
n 
on
 p
at
ie
nt
s w
ho
 w
er
e 
on
 d
iu
re
tic
 m
ed
ic
at
io
ns
. T
he
 p
ro
po
rti
on
s a
re
 o
nl
y 
fo
r t
ho
se
 p
re
sc
rib
ed
 fu
ro
se
m
id
e 
(n=
18
3),
 no
t th
e e
nti
re 
po
pu
lat
ion
 sa
mp
le.
b S
am
pl
e 
siz
e 
fo
r v
ar
ia
bl
es
 w
ith
 m
iss
in
g 
va
lu
es
.
B
M
I: 
bo
dy
 m
as
s i
nd
ex
; C
O
PD
: c
hr
on
ic
 o
bs
tru
ct
iv
e 
pu
lm
on
ar
y 
di
so
rd
er
; e
qu
.: 
eq
ui
va
le
nt
; N
Y
H
A
: N
ew
 Y
or
k 
H
ea
rt 
A
ss
oc
ia
tio
n;
 S
E:
 st
an
da
rd
 e
rro
r, 
U
rN
a:
 u
rin
e 
so
di
um
.
Eur J Cardiovasc Nurs. Author manuscript; available in PMC 2015 April 06.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Creber et al. Page 18
Table 3
Factors associated with higher sodium excretion (n=280).
Variables Adjusted OR 95% CI p-value
Cognition
Cognitively impaired 1.00 Reference
Cognitively intact 2.22 1.09–4.53 0.028
Body mass index
Normal (18–24) 1.00 Reference
Overweight (25–29) 1.79 0.75–4.25 0.187
Obese (30+) 2.90 1.15–4.25 <0.001
Diabetes
No 1.00 Reference
Yes 2.80 1.33–5.89 0.007
Gender
Female 1.00 Reference
Male 1.16 0.54–2.51 0.703
Age
≥65 years 1.00 Reference
<65 years 1.95 0.97–3.90 0.059
Hypertension 0.51 0.25–1.04 0.068
Income 1.11 0.67–1.84 0.696
Diuretic use 1.05 0.48–2.33 0.897
Heart failure etiology 0.72 0.31–1.67 0.438
Type of heart failure (systolic, diastolic, mixed) 1.24 0.78–1.98 0.351
Education 1.14 0.67–1.96 0.607
Race 1.17 0.57–2.42 0.663
OR: odds ratio; CI: confidence interval.
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